Lungs News and Research

RSS

miRNAs may generate new insights on cancer and possible future treatments

Scientists are methodically unlocking the biological processes that lead to cancer, and recent discoveries with microRNAs (miRNAs) are revolutionizing their understanding and leading to clinical trials of potentially effective treatments.

21 Apr 2010

Duke University Medical Center, LabCorp form joint venture to commercialize new biomarkers

Duke University Medical Center and Laboratory Corporation of America Holdings announced today the formation of a joint venture to commercialize new biomarkers. The new entity is designed to speed the translation of newly discovered biomarkers into widely available clinical tools that can measure individual therapeutic responses, predict disease progression, and evaluate any number of biologic or disease-causing processes.

21 Apr 2010

3M Littmann Model 3200 and Zargis Cardioscan software receive red dot design award

3M and Zargis Medical Corp., today announced that the 3M Littmann Electronic Stethoscope Model 3200 and the Zargis Cardioscan software recently received two industry awards for design and innovation: the "red dot: best of the best" award for product design, given by the Design Zentrum Nordrhein Westfalen, an internationally known design institution located in Essen, Germany, and the Medical Design Excellence Award, sponsored by Medical Device & Diagnostic Industry magazine.

21 Apr 2010

Gemin X Pharmaceuticals closes $16 million Series D financing

Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced the close of its $16 million Series D round of financing. Current investors Caxton Advantage Life Sciences Fund LP and Sanderling Venture Partners co-led the round. In addition, the Series D structure grants certain current investors the option to invest an additional $4 million in this financing round in the future.

21 Apr 2010

High BMI can raise risk of postmenopausal breast cancer

Reported mid-life increase in body mass index (BMI) may lead to substantially higher risk of postmenopausal breast cancer, according to results of a prospective cohort study presented at the American Association for Cancer Research 101st Annual Meeting 2010, held here April 17-21.

21 Apr 2010

ABRAXANE-bevacizumab combination therapy may exhibit potential in treatment of triple-negative breast cancers

Abraxis BioScience, Inc., a fully integrated biotechnology company, announced study results today that demonstrate a regimen of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) given in combination with bevacizumab (Avastin®) may have potential in the treatment of triple-negative breast cancers.

21 Apr 2010

AngioDynamics commences treatment in NanoKnife IRE System pilot study for HCC

AngioDynamics today announced the first patient treatment and growing enrollment in a pilot study of the use of the Company's NanoKnife® Irreversible Electroporation (IRE) System in the treatment of early stage hepatocellular carcinoma (HCC), or primary liver cancer. This clinical trial is being conducted under the supervision of Professor Jordi Bruix of the Barcelona Clinic Liver Cancer Group of the University of Barcelona and Professor Riccardo Lencioni of the University of Pisa School of Medicine.

20 Apr 2010

Study underscores potential for VBL Therapeutics VB-111 as broad-spectrum cancer therapy

VBL Therapeutics today announced positive results from preclinical and Phase 1 studies evaluating the company's lead anti-cancer agent, VB-111 - a first-in-class, targeted biological agent shown to work via dual-action, anti-angiogenic and vascular disruptive mechanism of action - in metastatic cancer. Preclinical data evaluating VB-111 in a comprehensive set of in vivo studies employing the Lewis Lung metastasis mouse model showed the compound to be safe and specific, with a 90% reduction in tumor burden of lung metastases after only one injection.

20 Apr 2010

First case of treating cystic fibrosis and Crohn's disease with infliximab

Cystic fibrosis (CF) is the most common life-threatening autosomal recessive disease in Caucasian children; it has an incidence of 1 case in every 2500 children born alive. CF involves an anomalous function of the exocrine glands, caused by a mutation of a gene (cystic fibrosis transmembrane conductance regulator, CFTR) located on chromosome 7, which codes for a protein involved in ion transport through the cell membrane.

20 Apr 2010

Positive data from NewLink Genetics Phase1/2 study of HyperAcute-Lung cancer immunotherapy

NewLink Genetics Corporation announced today data from a Phase 1/2 study showing that patients with progressive advanced non-small cell lung cancer treated with its HyperAcute®-Lung cancer immunotherapy experienced favorable median survival. The data were presented at the 101st American Association for Cancer Research (AACR) Annual Meeting.

20 Apr 2010

FDA-approved metformin can prevent tobacco-carcinogen induced lung tumors: Study

Metformin, a mainstay of treatment for patients with type 2 diabetes, may soon play a role in lung cancer prevention if early laboratory research presented here at the AACR 101st Annual Meeting 2010 is confirmed in clinical trials.

20 Apr 2010

Immunomedics develops E1-L-thP1 protein complex for targeted delivery of siRNAs to diverse solid cancers

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported the development of a novel protein complex, designated as E1-L-thP1, for targeted delivery of small interfering ribonucleic acids (siRNAs) to diverse solid cancers.

19 Apr 2010

Sentry Air Systems announces equipment compliance with OSHA's hexavalent chromium regulation

The Occupational Health and Safety Administration (OSHA) is enforcing strict regulations regarding worker exposure to hexavalent chromium in several industries. Hexavalent chromium, a volatized and oxidized form of chromium, has been identified as a carcinogen. OSHA has subsequently established stringent regulations for workers who are potentially exposed to it in the general, construction, shipyard, and marine terminal industries.

19 Apr 2010

End-of-life care documentation helps in emergency treatment decisions

When Heather Rubesch was a teenager, her aunt died in need of a kidney transplant. In later family discussions, Heather's mother, Linda, expressed some of her views about end-of-life care—for instance, her belief in organ donation.

19 Apr 2010

Radiolabeled hedgehog can differentiate stem-like cancer cells, identify aggressive tumors

At the American Association for Cancer Research 101st Annual Meeting 2010, scientists and clinicians will present more than 6,300 abstracts dealing with innovative aspects of biology, technology and emerging therapies.

19 Apr 2010

Results of BATTLE Trial presented at AACR 2010

Lung cancer is the number one cause of cancer death in men and women, but huge randomized trials of thousands of patients have either failed completely or shown negligible survival differences.

19 Apr 2010

Debate continues over prostate cancer screening in Europe

The European Association of Urology reiterated that it does not recommend a mass screening policy in Europe for men who are concerned over prostate cancer, a stance which reflects the position it issued last year regarding prostate cancer screening. "We don't believe that the time has come for mass screening," said EAU Secretary General.

19 Apr 2010

CCS organizes Women's Brunch on breast cancer screening

The Canadian Cancer Society (CCS) is organizing a Women's Brunch for the media, to remind women of the importance of screening as a way to fight breast cancer.

17 Apr 2010

Tools and applications of QI methodology in Neonatal-Perinatal practice

The March 2010 issue of Clinics in Perinatology, published by Elsevier, provides Neonatologists and Maternal-Fetal-Medicine specialists with the tools and concepts necessary to understand Quality Improvement (QI) methodology and to initiate QI projects within their own practices and neonatal intensive care units (NICUs).

17 Apr 2010

Breathe California names CODA Automotive as winner of Clean Air Award

CODA Automotive, a California-based electric car and battery company, was named a Clean Air Award winner in the technology development category by Breathe California. The award, presented today in San Francisco, highlights standout efforts to combat climate change and air pollution in the business, government, education and non-profit sectors.

17 Apr 2010

Lungs News and Research

miRNAs may generate new insights on cancer and possible future treatments

Duke University Medical Center, LabCorp form joint venture to commercialize new biomarkers

3M Littmann Model 3200 and Zargis Cardioscan software receive red dot design award

Gemin X Pharmaceuticals closes $16 million Series D financing

High BMI can raise risk of postmenopausal breast cancer

ABRAXANE-bevacizumab combination therapy may exhibit potential in treatment of triple-negative breast cancers

AngioDynamics commences treatment in NanoKnife IRE System pilot study for HCC

Study underscores potential for VBL Therapeutics VB-111 as broad-spectrum cancer therapy

First case of treating cystic fibrosis and Crohn's disease with infliximab

Positive data from NewLink Genetics Phase1/2 study of HyperAcute-Lung cancer immunotherapy

FDA-approved metformin can prevent tobacco-carcinogen induced lung tumors: Study

Immunomedics develops E1-L-thP1 protein complex for targeted delivery of siRNAs to diverse solid cancers

Sentry Air Systems announces equipment compliance with OSHA's hexavalent chromium regulation

End-of-life care documentation helps in emergency treatment decisions

Radiolabeled hedgehog can differentiate stem-like cancer cells, identify aggressive tumors

Results of BATTLE Trial presented at AACR 2010

Debate continues over prostate cancer screening in Europe

CCS organizes Women's Brunch on breast cancer screening

Tools and applications of QI methodology in Neonatal-Perinatal practice

Breathe California names CODA Automotive as winner of Clean Air Award

The ultimate guide to lung research tools and protocols eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News